Cellebrite DI (NASDAQ:CLBT) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.09 by 55.56 percent. The company reported quarterly sales of $106.858 million which beat the analyst consensus estimate of $101.929 million by 4.84 percent. This is a 26.94 percent increase over sales of $84.179 million the same period last year.